TERT and central nervous system cancer: Both in low-grade and high-grade gliomas, TERT mutations are linked to the subgroup with the worst prognosis (Eckel-Passow et al. 2015), (Suzuki et al. 2015), which aligns with the tumor maintenance role of telomerase.